Trygg implementering av HPV-testing i Livmorhalsprogrammet

Reaching for Zero is a service design diploma made in collaboration with The Norwegian Cervical Cancer Screening Programme (NCCSP), wich as part of The Cancer Registry

In order to determine whether HR-HPV E6/E7 mRNA testing more effectively predicts precancerous lesions and invasive cervical cancer than HR-HPV DNA testing, we aimed to compare

Relation of human papillomavirus status to cervical lesions and consequences for cervical- cancer screening: a

Cost-effectiveness of cervical cancer screening with primary 428 human papillomavirus testing in Norway. British journal

Existence of many societal behavioural patterns in Nepal that are risk to cervical cancer and present opportunistic cervical cancer screening services which have low coverage rate

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway.. Eurpoean giudelines for quality assurance in cervical

Litteratursøket identifiserte også en Cochrane-protokoll, ”HPV testing versus cervical cytology for screening for cancer of the uterine cervix”, fra 2003 som vil bestemme verdien

The aim of this report was to determine the cost-effectiveness of HPV vaccination includ- ing types 16/18 in 12-year-old girls alongside the existing cervical cancer screening